EE367 Cost-Effectiveness Analysis of Upadacitinib As a Treatment Option for Patients with Rheumatoid Arthritis in Kingdom of Saudi Arabia
Abstract
Authors
H Alabdulkarim H Almodaimegh LC Abu Esba Y Sharma S Attar W Hussain I Alhomood BA Al-Omari O Mohamed M Alsaqa’aby A Roshdy A Anwar T Hamad Z Alzahrani